Related Experiment Video
Updated: Jun 16, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
[Ketamine in melancholic depression]
Johannes Bjerre1, Claus Fontenay
1Psykiatrien i Region Syddanmark, Esbjerg, Denmark. johannesbjerre@hotmail.com
Abstract:
A 35-year-old male known with bipolar disorder was admitted after a suicide attempt with cuts in both wrists. The patient had a major depression with melancholic symptoms and nihilistic delusions. To relieve the patient's agony in the days before electroconvulsive therapy and to reduce the risk of suicide, the patient was treated with S-ketamine 0,5 mg/kg. The patient's symptoms were reduced two hours after treatment and the effect was measurable for five days.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antidepressant Drugs: MAOIs and Other Agents
Electroconvulsive Therapy
Parenteral Anesthetics: Overview
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
